House Patent Reform Bill: Battle Looms Over Patent Reexamination Provisions
This article was originally published in The Gray Sheet
Executive Summary
The six-year battle over patent reform legislation is not yet over as the device and drug industries and other leading industry stakeholders are unhappy with provisions in the House bill that differ from the recently passed Senate measure.
You may also be interested in...
Patent Bill Drama Moves To House As Senate Hands Brand Pharma Victory
With the Senate poised to approve its version of the patent reform bill, House Judiciary Committee Chairman Lamar Smith, R-Texas, will soon be in the driver's seat of a piece of legislation that could significantly alter the relationships pharmaceutical companies have with both their licensing partners and generic adversaries.
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.